% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Markaki:154382,
author = {Markaki, Ioanna and Bergström, Sofia and Tsitsi, Panagiota
and Remnestål, Julia and Månberg, Anna and Hertz, Ellen
and Paslawski, Wojciech and Sorjonen, Kimmo and Uhlén,
Mathias and Mangone, Graziella and Carvalho, Stephanie and
Rascol, Olivier and Meissner, Wassilios G and Magnin, Eloi
and Wüllner, Ullrich and Corvol, Jean-Christophe and
Nilsson, Peter and Svenningsson, Per},
title = {{C}erebrospinal {F}luid {L}evels of {K}ininogen-1
{I}ndicate {E}arly {C}ognitive {I}mpairment in {P}arkinson's
{D}isease.},
journal = {Movement disorders},
volume = {35},
number = {11},
issn = {1531-8257},
address = {New York, NY},
publisher = {Wiley},
reportid = {DZNE-2021-00235},
pages = {2101 - 2106},
year = {2020},
note = {ISSN 1531-8257 not unique: **3 hits**.},
abstract = {Cognitive impairment is common in patients with PD. Core
markers of Alzheimer's dementia have been related also to PD
dementia, but no disease-specific signature to predict PD
dementia exists to date.The aim of this study was to
investigate CSF markers associated with cognition in early
PD.A high-throughput suspension bead array examined 216
proteins in CSF of 74 PD patients in the AETIONOMY project.
Cognitive function was assessed with Repeatable Battery for
the Assessment of the Neuropsychological Status, Montreal
Cognitive Assessment, and Mini-Mental State Examination.Of
69 patients with complete data, 34 had high (≥90) and 35
had low Repeatable Battery for the Assessment of the
Neuropsychological Status total score (<90). Of 14 proteins
in CSF that differed in levels between groups, increased
kininogen-1, validated with several antibodies, was
independently associated with lower Repeatable Battery for
the Assessment of the Neuropsychological Status and Montreal
Cognitive Assessment scores after adjustment for
confounders.Kininogen-1 levels in CSF may serve as a marker
of cognitive impairment in PD. © 2020 The Authors. Movement
Disorders published by Wiley Periodicals LLC on behalf of
International Parkinson and Movement Disorder Society.},
keywords = {Cognition Disorders: diagnosis / Cognition Disorders:
etiology / Cognitive Dysfunction: etiology / Humans /
Kininogens / Mental Status and Dementia Tests /
Neuropsychological Tests / Parkinson Disease: complications
/ Parkinson's disease (Other) / cognition (Other) /
kininogen-1 (Other) / neurodegeneration (Other)},
cin = {AG Wüllner ; AG Wüllner 2},
ddc = {610},
cid = {I:(DE-2719)1011302},
pnm = {344 - Clinical and Health Care Research (POF3-344)},
pid = {G:(DE-HGF)POF3-344},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:33179332},
doi = {10.1002/mds.28192},
url = {https://pub.dzne.de/record/154382},
}